Royce & Associates’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$9.6M Buy
222,305
+30,523
+16% +$1.32M 0.1% 298
2025
Q1
$6.63M Buy
191,782
+46,994
+32% +$1.62M 0.07% 387
2024
Q4
$3.97M Buy
144,788
+22,833
+19% +$627K 0.04% 529
2024
Q3
$3.1M Buy
+121,955
New +$3.1M 0.03% 558